PriceTargets.com logo

Ascend Wellness - AAWH Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 1 Strong Buy Ratings
$0.37 As of 11/25/2024 01:00 AM ET
▼ -0.02 (-5.13%)

This chart shows the closing price for AAWH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ascend Wellness Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AAWH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AAWH

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Ascend Wellness in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.37.

This chart shows the closing price for AAWH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Ascend Wellness. This rating has held steady since June 2024, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/4/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/2/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/29/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/29/2024
  • 1 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/27/2024
  • 1 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2024
  • 1 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/25/2024

Latest Recommendations

  • 1 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/16/2024Ventum Cap MktsUpgradeStrong-Buy
5/7/2024Needham & Company LLCReiterated RatingHold
7/4/2023Atb Cap MarketsReiterated RatingOutperform
5/19/2023Needham & Company LLCDowngradeBuy ➝ Hold
3/15/2023Needham & Company LLCReiterated RatingBuy$2.75
2/10/2023Cantor FitzgeraldInitiated CoverageNeutral
10/28/2022BTIG ResearchInitiated CoverageBuy
7/22/2022Seaport Res PtnReiterated RatingBuy
3/9/2022Needham & Company LLCLower TargetBuy$11.00 ➝ $9.00
1/4/2022Needham & Company LLCLower Target$13.00 ➝ $11.00
12/7/2021Echelon Wealth PartnersReiterated RatingBuy
(Data available from 11/26/2019 forward)

News Sentiment Rating

1.29 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/30/2024
  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/30/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/29/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2024
  • 3 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
8/28/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2024
  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2024

Current Sentiment

  • 6 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Ascend Wellness logo
Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York.
Read More

Today's Range

Now: $0.37
Low: $0.37
High: $0.40

50 Day Range

MA: $0.75
Low: $0.37
High: $0.99

52 Week Range

Now: $0.37
Low: $0.37
High: $1.82

Volume

456,566 shs

Average Volume

227,374 shs

Market Capitalization

$79.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

Frequently Asked Questions

What sell-side analysts currently cover shares of Ascend Wellness?

The following Wall Street research analysts have issued reports on Ascend Wellness in the last twelve months: Needham & Company LLC, and Ventum Cap Mkts.
View the latest analyst ratings for AAWH.

What is the current price target for Ascend Wellness?

0 Wall Street analysts have set twelve-month price targets for Ascend Wellness in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Ascend Wellness in the next year.
View the latest price targets for AAWH.

What is the current consensus analyst rating for Ascend Wellness?

Ascend Wellness currently has 1 hold rating and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AAWH will outperform the market and that investors should add to their positions of Ascend Wellness.
View the latest ratings for AAWH.

What other companies compete with Ascend Wellness?

Other companies that are similar to Ascend Wellness include Kamada, Sage Therapeutics, Cryoport, Design Therapeutics and Neurogene. Learn More about companies similar to Ascend Wellness.

How do I contact Ascend Wellness' investor relations team?

Ascend Wellness' physical mailing address is 1411 Broadway 16th Floor, New York NY, 10018. The company's listed phone number is 646-661-7600 and its investor relations email address is [email protected]. The official website for Ascend Wellness is www.awholdings.com. Learn More about contacing Ascend Wellness investor relations.